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Supplementary material
: Expression constructs used in this study Besides wt TMD0 (M1 -P142) a cf expression version of TMD0 (cf-TMD0) was used, in which arginine at position two was replaced by lysine, and tryptophan at position four was substituted by tyrosine. Moreover, all four cysteines were replaced by alanine. For E. coli based cf expression system, four different tagged variants were generated: cf-TMD0-His contains a C-terminal His10-tag, cf-TMD0-myc a C-terminal myc-tag (EQKLISEEDL), cf-TMD0-myc/His and cf-TMD0-Flag/His contain an additional myc-or Flag-tag (DYKDDDDK) in front of the His10-tag. Furthermore two single cysteine versions of cf-TMD0-His were used, in which serine at position 28 or 138 was replaced by cysteine. For mammalian expression in HEK 293T cells, C-terminal myc-or Flag-tagged TMD0 and cf-TMD0 were used as well as coreTAPL (G143 -A766) and TAPL (M1 -A766). CoreTAPLmV with a C-terminal mVenus followed by His10-tag was used for expression in P. pastoris, heterodimeric TmrA with a C-terminal His10-tag and TmrB were used for expression in E.
coli. Figure S2 : Solubilization, purification and refolding of cf-TMD0-His Cf-TMD0-His was expressed in an E. coli based cf expression system in the absence of detergent (exp). Precipitate was solubilized with 1% LMPG (sol) for 2 h at room temperature, and flow through (FT) was collected after binding to Ni-NTA-agarose for 2 h at room temperature. For refolding, detergent was exchanged during IMAC purification in 5 consecutive washing steps from LMPG to 0.75% c6-DHPC (W1 -W5) prior to elution and buffer exchange to NMR sample buffer (E). Purification was analyzed by Tricine-SDS-PAGE (10%) followed by Coomassie staining (top) or immunoblotting with His-tag specific antibody (bottom). Identical aliquots are loaded except flow through and washing steps, which were loaded in a 10-fold excess. 
